CareDx, Inc. CDNA

NASDAQHealth TechnologyUnited States

$77.88-1.93 (-2.42%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 76.6780.00
52-week range: 15.1590.87

Financial health

– / 5

Analyst view · 8 firms

Buy6 buy · 2 hold · 0 sell

Avg. target $94.43 (+21.2%)

Prices may be delayed and are for informational purposes only - not investment advice.

CareDx, Inc. CDNA

NASDAQHealth TechnologyUnited States

$77.88-1.93 (-2.42%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 76.6780.00
52-week range: 15.1590.87

Financial health

– / 5

Analyst view · 8 firms

Buy6 buy · 2 hold · 0 sell

Avg. target $94.43 (+21.2%)

Valuation from filings

Calculated from the tables below and the current price ($77.88) · LTM · 2026/9 · 2026-09-30

P/E: 32.59EPS $2.39
P/B: 8.97BV/share $8.68
P/S: 8.43Sales/share $9.24
Return on equity: 27.5%Net income / equity
Net margin: 25.9%Operating margin 23.4%
Free cash flow yield: —Free cash flow / market cap

Revenue and net income

Fiscal year · $ millions · net margin below

RevenueNet Income

Financial statements

$ thousands · Under each value: change against a year earlier

Upgrade to MakklerPRO to see every row.Upgrade to MakklerPRO

Fiscal year	2021	2022	2023	2024	2025	LTM
Income Statement
Revenue	296,397	321,793+9%	280,324-13%	333,785+19%	379,805+14%	497,396
Operating expenses
Operating Income
EBITDA
Pre-tax income
Income tax (expense) / benefit
Net Income	(30,662)	(76,613)+150%	(190,284)+148%	52,549turned profitable	(21,354)turned to a loss	128,629
Earnings per share ($)
Margins
Operating margin
EBITDA margin
Net margin

Taken from the company's own 10-K and 10-Q filings via the SEC's XBRL data service. The "LTM" column is the last completed fiscal year plus the current year to date, minus the same period a year earlier. Lines a company tags with a non-standard label are left blank rather than filled with an approximation. Not investment advice.